Evidence map›Paper›PMID 37366873›Full record

ReviewDiseases (Basel, Switzerland)2023

Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease.

Julia Prinz, Nicola Maffulli, Matthias Fuest, Peter Walter, Frank Hildebrand, Filippo Migliorini

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diseases (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. How Advanced are Nanocarriers for Effective Subretinal Injection?International journal of nanomedicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Julia PrinzRWTH University Hospital of Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Nicola MaffulliDepartment of Medicine, Surgery and Dentistry, University of Salerno, 84081 Fisciano, Italy.ORCID 0000-0002-5327-3702
Matthias FuestRWTH University Hospital of Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0002-0573-2599
Peter WalterRWTH University Hospital of Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0001-8745-6593
Frank HildebrandRWTH University Hospital of Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
Filippo MiglioriniRWTH University Hospital of Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.ORCID 0000-0001-7220-1221
RWTH Aachen University · DEOspedale di Bolzano · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of chloroquine (CQ) and hydroxychloroquine (HCQ) in the management of dry eye disease is still unclear. This systematic review and meta-analysis investigates the efficacy and feasibility of CQ and HCQ in patients with dry eye disease. In February 2023, PubMed, Embase, Google Scholar, and Web of Science were accessed. Data from 462 patients (mean age 54.4 ± 2.8 years) were collected. Compared to baseline, the tear breakup time (

Indexed as

chloroquinedry eye diseasehydroxychloroquinekeratoconjunctivitis siccaxerophthalmus

Identifiers

PMID37366873
PMCPMC10297605
OpenAlexW4380324416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.